Literature DB >> 22087736

Self-assessment and objective determination of dexterity in patients with type 1 or type 2 diabetes mellitus.

Andreas Pfützner1, P B Musholt, C Schipper, M Niemeyer, M Qvist, A Schorsch, T Forst.   

Abstract

OBJECTIVE: Insulin-treated patients perform complex treatment activities during daily routine, such as blood glucose measurements and insulin injections. We aimed to identify suitable dexterity and cognitive function tests for diabetes patients, and to compare the patient self-assessment of their dexterity skills with the test results (Jebsen-Taylor hand function test, (JHFT), motoric performance test (MLS), number connection test).
METHOD: We enrolled 90 diabetes patients (36 females, 54 males): 15 type 1 with clinically suspected dexterity impairment (A: age: 60 ± 9 years), 30 type 2 with clinically suspected dexterity impairment (B: 61 ± 10 years), 30 type 1 or type 2 patients with visual impairment (C: 64 ± 6 years), and 15 type 1 or type 2 patients without obvious impairment (control group: D: 64 ± 5 years).
RESULTS: There were no differences regarding neuropathy and slight impairments in the number connection test in all groups. Patient self-assessment revealed that 33.4% in group A, 33.3% in group B, 36.7% in group C and 13.7% in group D, considered themselves to have dexterity impairment. However in the JHFT test, all patients from A (100%) and B (100%), 33% from C, and 0% from D presented with dexterity impairment by only passing less than four subtests.
CONCLUSIONS: Impairment of dexterity was much more frequent than believed by the patients themselves. It may be worthwhile to consider these findings when classifying patients regarding their capabilities to perform certain treatments or when assessing diabetes technology with human subjects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22087736     DOI: 10.1185/03007995.2011.638911

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  5 in total

1.  FlexTouch: An Insulin Pen-Injector with a Low Activation Force Across Different Insulin Formulations, Needle Technologies, and Temperature Conditions.

Authors:  Niels Gudiksen; Thibaud Hofstätter; Birgitte B Rønn; Thomas Sparre
Journal:  Diabetes Technol Ther       Date:  2017-07-13       Impact factor: 6.118

2.  Modeling metabolic syndrome and its association with cognition: the Northern Manhattan study.

Authors:  Bonnie E Levin; Maria M Llabre; Chuanhui Dong; Mitchell S V Elkind; Yaakov Stern; Tatjana Rundek; Ralph L Sacco; Clinton B Wright
Journal:  J Int Neuropsychol Soc       Date:  2014-11-10       Impact factor: 2.892

3.  Comparison of patient preference for two insulin injection pen devices in relation to patient dexterity skills.

Authors:  Andreas Pfützner; Christina Schipper; Marcus Niemeyer; Marianne Qvist; Andrea Löffler; Thomas Forst; Petra B Musholt
Journal:  J Diabetes Sci Technol       Date:  2012-07-01

4.  The associations among hand dexterity, functional performance, and quality of life in diabetic patients with neuropathic hand from objective- and patient-perceived measurements.

Authors:  Chien-Ju Yang; Hsiu-Yun Hsu; Chieh-Hsiang Lu; Yen-Li Chao; Haw-Yen Chiu; Li-Chieh Kuo
Journal:  Qual Life Res       Date:  2014-07-14       Impact factor: 4.147

5.  Do we underestimate influences of diabetic mononeuropathy or polyneuropathy on hand functional performance and life quality?

Authors:  Chien-Ju Yang; Hsiu-Yun Hsu; Chieh-Hsiang Lu; Yen-Li Chao; Haw-Yen Chiu; Li-Chieh Kuo
Journal:  J Diabetes Investig       Date:  2017-04-25       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.